Skip to content

S. 113 · 118th Congress (2023–2025)

Prescription Pricing for the People Act of 2023

Prescription Pricing for the People Act of 2023

This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.

Show official title

A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReported by committee

This bill’s path

This is S. 113’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Chuck Grassley (R-IA)
Cosponsors
21 cosponsors

8 original · 13 later

10 R · 10 D · 1 I

  1. Sen. Marsha Blackburn (R-TN)· Original · Jan 26, 2023
  2. Sen. Richard Blumenthal (D-CT)· Original · Jan 26, 2023
  3. Sen. Mike Braun (R-IN)· Original · Jan 26, 2023
  4. Sen. Maria Cantwell (D-WA)· Original · Jan 26, 2023
  5. Sen. Shelley Moore Capito (R-WV)· Original · Jan 26, 2023
  6. Sen. James Lankford (R-OK)· Original · Jan 26, 2023
  7. Sen. Tommy Tuberville (R-AL)· Original · Jan 26, 2023
  8. Sen. Thom Tillis (R-NC)· Original · Jan 26, 2023
  9. Sen. John Boozman (R-AR)· Later · Jan 30, 2023
  10. Sen. Christopher A. Coons (D-DE)· Later · Feb 7, 2023
  11. Sen. Peter Welch (D-VT)· Later · Feb 7, 2023
  12. Sen. Dianne Feinstein (D-CA)· Later · Feb 9, 2023
  13. Sen. Mazie K. Hirono (D-HI)· Later · Feb 9, 2023
  14. Sen. Robert P. Casey Jr. (D-PA)· Later · Mar 16, 2023
  15. Sen. Kyrsten Sinema (I-AZ)· Later · Mar 21, 2023
  16. Sen. Roger Marshall (R-KS)· Later · Mar 29, 2023
  17. Sen. Ted Budd (R-NC)· Later · Apr 19, 2023
  18. Sen. Jacky Rosen (D-NV)· Later · Sep 27, 2023
  19. Sen. Susan M. Collins (R-ME)· Later · Nov 9, 2023
  20. Sen. Jeanne Shaheen (D-NH)· Later · Nov 9, 2023
  21. Sen. Raphael G. Warnock (D-GA)· Later · Jul 10, 2024
Policy area
Commerce
Subjects
  • Business ethics
  • Business records
  • Competition and antitrust
  • Congressional oversight
  • Consumer affairs
  • Health care costs and insurance
  • Health information and medical records
  • Inflation and prices
  • 2 more
    • Prescription drugs
    • Retail and wholesale trades

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Jan 26, 2023 – Mar 1, 2023
    1. Referred to committee

      Read twice and referred to the Committee on the Judiciary.

      Sources
    2. Ordered reported

      Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

      Sources
    3. Reported by committee

      Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

      Sources
  3. Expired

    Introduced → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. SenateJudiciaryReferred Jan 26, 2023 · Markup Feb 9, 2023 · Reported Mar 1, 2023
    1. Feb 9, 2023 · Meeting

      Business meeting to consider committee rules, an original resolution authorizing expenditures by the committee for the 118th Congress, S.79, to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, S.113, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, S.142, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products, S.148, to enable to Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, S.150, to amend the Federal Trade Commission Act to prohibit product hopping, and the nominations of Nancy G. Abudu, of Georgia, to be United States Circuit Judge for the Eleventh Circuit, Rachel Bloomekatz, of Ohio, to be United States Circuit Judge for the Sixth Circuit, Anthony Devos Johnstone, of Montana, to be United States Circuit Judge for the Ninth Circuit, Julie Rikelman, of Massachusetts, to be United States Circuit Judge for the First Circuit, Robert Stewart Ballou, to be United States District Judge for the Western District of Virginia, Nusrat Jahan Choudhury, Natasha C. Merle, and Ramon Ernesto Reyes, Jr., each to be United States District Judge for the Eastern District of New York, Jessica G. L. Clarke, Dale E. Ho, and Arun Subramanian, each to be a United States District Judge for the Southern District of New York, Todd E. Edelman, to be United States District Judge for the District of Columbia, Kymberly Kathryn Evanson, to be United States District Judge for the Western District of Washington, Gordon P. Gallagher, to be United States District Judge for the District of Colorado, Jonathan James Canada Grey, to be United States District Judge for the Eastern District of Michigan, Myong J. Joun, and Julia E. Kobick, both to be a United States District Judge for the District of Massachusetts, Kenly Kiya Kato, and Hernan D. Vera, both to be a United States District Judge for the Central District of California, Colleen R. Lawless, to be United States District Judge for the Central District of Illinois, Rita F. Lin, and P. Casey Pitts, both to be a United States District Judge for the Northern District of California, Andrew G. Schopler, and James Edward Simmons, Jr., both to be a United States District Judge for the Southern District of California, and Rosemarie Hidalgo, of the District of Columbia, to be Director of the Violence Against Women Office, Amy Lefkowitz Solomon, of the District of Columbia, to be an Assistant Attorney General, Kate E. Brubacher, to be United States Attorney for the District of Kansas, Ismail J. Ramsey, to be United States Attorney for the Northern District of California, and Jill E. Steinberg, to be United States Attorney for the Southern District of Georgia, all of the Department of Justice.

    2. Feb 2, 2023 · Meeting

      Business meeting to consider S.79, to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, S.113, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, an original bill entitled, "Stop STALLING Act", an original bill entitled "Preserve Access to Affordable Generics and Biosimilars Act", an original bill entitled, "Affordable Prescriptions for Patients Act", and the nominations of Nancy G. Abudu, of Georgia, to be United States Circuit Judge for the Eleventh Circuit, DeAndrea Gist Benjamin, of South Carolina, to be United States Circuit Judge for the Fourth Circuit, Rachel Bloomekatz, of Ohio, to be United States Circuit Judge for the Sixth Circuit, Cindy K. Chung, of Pennsylvania, to be United States Circuit Judge for the Third Circuit, Bradley N. Garcia, of Maryland, to be United States Circuit Judge for the District of Columbia Circuit, Anthony Devos Johnstone, of Montana, to be United States Circuit Judge for the Ninth Circuit, Maria Araujo Kahn, of Connecticut, to be United States Circuit Judge for the Second Circuit, Julie Rikelman, of Massachusetts, to be United States Circuit Judge for the First Circuit, Daniel J. Calabretta, to be United States District Judge for the Eastern District of California, Tiffany M. Cartwright, Jamal N. Whitehead, and Kymberly Kathryn Evanson, each to be a United States District Judge for the Western District of Washington, Nusrat Jahan Choudhury, Natasha C. Merle, and Ramon Ernesto Reyes, Jr., each to be a United States District Judge for the Eastern District of New York, Jessica G. L. Clarke, Dale E. Ho, and Arun Subramanian, each to be a United States District Judge for the Southern District of New York, Matthew L. Garcia, to be United States District Judge for the District of New Mexico, Margaret R. Guzman, Myong J. Joun, and Julia E. Kobick, each to be a United States District Judge for the District of Massachusetts, Lindsay C. Jenkins, to be United States District Judge for the Northern District of Illinois, Kenly Kiya Kato, and Hernan D. Vera, both to be a United States District Judge for the Central District of California, Araceli Martinez-Olguin, Rita F. Lin, and P. Casey Pitts, each to be a United States District Judge for the Northern District of California, Gina R. Mendez-Miro, to be United States District Judge for the District of Puerto Rico, Adrienne C. Nelson, to be United States District Judge for the District of Oregon, Ana C. Reyes, and Todd E. Edelman, both to be a United States District Judge for the District of Columbia, Jamar K. Walker, to be United States District Judge for the Eastern District of Virginia, Robert Stewart Ballou, to be United States District Judge for the Western District of Virginia, Gordon P. Gallagher, to be United States District Judge for the District of Colorado, Jonathan James Canada Grey, to be United States District Judge for the Eastern District of Michigan, Colleen R. Lawless, to be United States District Judge for the Central District of Illinois, Andrew G. Schopler, James Edward Simmons, Jr., both to be a United States District Judge for the Southern District of California, and Rosemarie Hidalgo, of the District of Columbia, to be Director of the Violence Against Women Office, Amy Lefkowitz Solomon, of the District of Columbia, to be an Assistant Attorney General, and Jill E. Steinberg, to be United States Attorney for the Southern District of Georgia, all of the Department of Justice.

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Prescription Pricing for the People Act of 2023

    Display title, Short title · Introduced in Senate, Reported to Senate

  2. A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

    Official title · Introduced in Senate